NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Effects of storage time and exogenous protease inhibitors on plasma protein levels.

Author(s): Ayache S, Panelli M, Marincola FM, Stroncek DF

Publication: Am J Clin Pathol, 2006, Vol. 126, Page 174-84

PubMed ID: 16891190 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of protease inhibitors, centrifugation speed, and delayed separation of plasma on the levels of 97 chemokines and cytokines.

Conclusion of Paper

Storage of whole blood for 2 hours at room temperature prior to separation of plasma resulted in significant increases in protein levels for 37 of the 97 chemokines and cytokines assayed when compared to plasma specimens that were prepared immediately (p< 0.01). The use of protease inhibitors in the collection tube resulted in few changes in protein profiles. Different centrifugation speeds and durations resulted in no significant changes in protein profiles.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of protease inhibitors, centrifugation at 1600 x g for 15 min rather than 2500 x g for 8 min, and delayed separation of plasma on the levels of 97 chemokines and cytokines.

    Summary of Findings:

    Storage of whole blood for 2 hours at room temperature prior to separation of plasma resulted in significant increases in the levels of 37 of 97 proteins in EDTA plasma and 31 of 97 proteins in EDTA plus protease inhibitor plasma when compared to plasma specimens that were prepared immediately (p< 0.01). These included 15 interleukins, 4 metalloproteases, and 10 growth factors. In addition, the level of NT-proBNP decreased significantly in plasma with protease inhibitors after 2 hours of storage. The average magnitude of the changes in protein levels ranged between 1.18-fold and 17.5-fold. The use of protease inhibitors resulted in significant changes in plasminogen activator inhibitor-1 (PAI-1), Eotaxin 2, Exodus II, and NT-proBNP when plasma was prepared immediately and PAI-1, matrix metalloprotease-2, tissue inhibitor of metalloprotease-2, and intracellular adhesion molecule-1 when whole blood was left at room temperature for 2 hours. This led the authors to conclude that the use of protease inhibitors, with or without a modified inner capsule in the collection tube, did not result in overall significant changes in protein profiles. Furthermore, the use of different centrifugation speeds and durations for separation of plasma did not significantly alter protein profiles.

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Protein ELISA
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Time at room temperature 0 h
    2 h
    Storage Storage temperature -80 degrees C
    Analyte Extraction and Purification Protease inhibitor No protease inhibitor added
    Added prior to analysis
    Biospecimen Acquisition Type of collection container/solution Standard EDTA tubes
    EDTA plus protease inhibitors
    EDTA plus protease inhibitors with modified inner capsule
    Biospecimen Aliquots and Components Centrifugation Multiple durations compared
    Multiple speeds compared
    Centrifugation delays investigated

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...